Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - November 2012


Conference on Instrumentations and Biotechnologies 2012

12 Nov 2012 - 14 Nov 2012 - Shanghai Everbright International Hotel



Bookmark and Share


Mission

CIB promotes scientific communication between academics and companies with interests in biotechnologies and instrumentations.

CIB Objectives

Create a platform and an opportunity for scientists, clinicians and researchers to communicate about topics in advanced biotechnologies and instrumentations for application to clinical research.
Act as a bridge between academics and companies to understand the development of advanced biotechnologies instrumentations, and their potential for commercialization and clinical application.
Strengthen and enhance academic dialogue and information exchange between biotechnology companies, industries and manufacturers, thereby facilitating the development of collaborative projects or partnerships.

Discuss the use of new instrumentations and devices in clinical practice and feed back experience of the instrumentations and devices to the manufacturers

Focuses

1.    Cyto-pharmacology, metabolism, efficacy and survival
2.    The use of clinical proteomic technologies, tissue imaging proteomics, antibody microarray and biomarkers for diagnosis, therapy and prognosis of disease
3.    Clinical gene microarray technologies in diagnosis of disease
4.    Cellular mathematics, biophysics, bioinformatics and computational biology
5.    Functional and molecular imaging, cellular imaging, tissue imaging and in vivo imaging
6.    Flow cytometry, cellomics, metabomics, and stem cell biology
7.    Organ functional measurements
8.    Laser capture microdissection, molecular pathologies, tissue microarray, digital imaging analysis and morphometric systems
9.    Experimental magnetic resonance imaging (MRI), positron emission tomography (PET), single photon emission computed tomography (SPECT), thermography, and ultrasound imaging technologies
10.   Tissue bioengineering technologies

Audience and participants

Scientists, clinicians, researchers and students from universities, institutes, hospitals, and companies working on medical biotechnologies and instrumentations.



Further information
Scientific News
New Cancer Drug Target in Dual-Function Protein
Scientists at The Scripps Research Institute (TSRI) have identified a protein that launches cancer growth and appears to contribute to higher mortality in breast cancer patients.
Penn State, TB Alliance, and GSK Partner To Discover New Treatments For TB
A new collaboration between TB Alliance, GSK, and scientists in the Eberly College of Science seeks to find new small molecules that can be used to create antibiotics in the fight against tuberculosis (TB).
Molecular Map Provides Clues To Zinc-Related Diseases
Mapping the molecular structure where medicine goes to work is a crucial step toward drug discovery against deadly diseases.
Platelets are the Pathfinders for Leukocyte Extravasation During Inflammation
Findings from the study could help in the prevention and treatment of inflammatory pathologies.
Genetic Research Can Significantly Improve Drug Development
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
New Method Opens Door to Development of Many New Medicines
Findings from TSRI reveal human proteins are better drug targets than previously thought.
Diagnosing Systemic Infections Quickly, Reliably
Team develop rapid and specific diagnostic assay that could help physicians decide within an hour whether a patient has a systemic infection and should be hospitalized for aggressive intervention therapy.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Blood Test That Detects Early Alzheimer’s Disease
A research team, led by Dr. Robert Nagele from Rowan University School of Osteopathic Medicine and Durin Technologies, Inc., has announced the development of a blood test that leverages the body’s immune response system to detect an early stage of Alzheimer’s disease – referred to as the mild cognitive impairment (MCI) stage – with unparalleled accuracy.
A New Approach to Chemical Synthesis
Communesins, originally found in fungus, could hold potential as cancer drugs.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!